Inhibition of human placental progesterone synthesis by danazol in vitro

Lab / animal OA: closed CC0 ⤵ 2 in-corpus citations
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-10 ⓘ

Danazol was found to inhibit progesterone synthesis in human placental tissue samples incubated in vitro.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

In vitro, danazol showed a slight dose-dependent inhibition of the mitochondrial cholesterol side chain cleavage enzyme isolated from early gestational (8th to 12th week of gestation) placenta. In the presence of 100 microM danazol, the enzyme activity was 65% of controls. Danazol inhibits dose-dependently the mitochondrial 3 beta-hydroxysteroid dehydrogenase (I50 = 3.1 microM; Ki = 1 microM) (noncompetitive inhibition) and the cytoplasmic 20 alpha-hydroxysteroid dehydrogenase (I50 = 1.4 microM; Ki = 2.6 microM) (competitive inhibition). The inhibition of human placental progesterone synthesis by danazol in vitro is a further example for the direct interference of danazol with steroidogenesis.

My notes (saved in your browser only)

MeSH descriptors

Danazol Placenta Pregnadienes Progesterone 20-Hydroxysteroid Dehydrogenases 20-Hydroxysteroid Dehydrogenases 3-Hydroxysteroid Dehydrogenases 3-Hydroxysteroid Dehydrogenases Danazol Dose-Response Relationship, Drug Female Humans In Vitro Techniques Mitochondria Mitochondria Placenta Placenta Pregnadienes Pregnancy Pregnancy Trimester, First

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cites (2)

Cited by (2)

References (12)

Cited by (2)

Source provenance

openalex
last seen: 2026-05-14T06:16:54.145842+00:00
pubmed
last seen: 2026-10-08T21:58:20.576574+00:00
unpaywall
last seen: 2026-10-11T06:28:45.473802+00:00
License: CC0 · commercial use OK